BlackRock Institutional Trust’s Enzo Biochem, Inc. ENZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$10.6M Sell
1,528,737
-31,587
-2% -$202K ﹤0.01% 2366
2016
Q3
$7.94M Sell
1,560,324
-68,259
-4% -$408K ﹤0.01% 2473
2016
Q2
$9.72M Buy
1,628,583
+315,111
+24% +$1.75M ﹤0.01% 2303
2016
Q1
$5.98M Buy
1,313,472
+68,656
+6% +$306K ﹤0.01% 2562
2015
Q4
$5.6M Sell
1,244,816
-13,907
-1% -$58.7K ﹤0.01% 2652
2015
Q3
$3.99M Buy
1,258,723
+8,716
+0.7% +$26.4K ﹤0.01% 2824
2015
Q2
$3.79M Sell
1,250,007
-279,441
-18% -$786K ﹤0.01% 2866
2015
Q1
$4.51M Buy
1,529,448
+57,005
+4% +$187K ﹤0.01% 2794
2014
Q4
$6.54M Buy
1,472,443
+15,372
+1% +$73.3K ﹤0.01% 2608
2014
Q3
$7.5M Buy
1,457,071
+47,534
+3% +$254K ﹤0.01% 2484
2014
Q2
$7.4M Buy
1,409,537
+312,599
+28% +$1.35M ﹤0.01% 2601
2014
Q1
$4.56M Buy
1,096,938
+214,781
+24% +$736K ﹤0.01% 2822
2013
Q4
$2.58M Buy
882,157
+96,562
+12% +$239K ﹤0.01% 3060
2013
Q3
$1.98M Sell
785,595
-81,365
-9% -$193K ﹤0.01% 3135
2013
Q2
$1.8M Buy
+866,960
New +$1.91M ﹤0.01% 3132

Other funds holding ENZ

BlackRock Institutional Trust's ENZ Position: Q4 2016 in Review

BlackRock Institutional Trust reduced its Enzo Biochem, Inc. (ENZ) stake by 2% in Q4 2016, selling an estimated $202K and leaving 1,528,737 shares worth $10.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2366.

BlackRock Institutional Trust first reported a position in ENZ in Q2 2013 and has held it in 15 quarters since. 109 funds tracked by Wall St. Rank hold ENZ as of Q4 2016.

  • BlackRock Institutional Trust held 1,528,737 shares of Enzo Biochem, Inc. worth $10.6M as of Q4 2016.
  • BlackRock Institutional Trust sold 31,587 Enzo Biochem, Inc. shares in Q4 2016, an estimated $202K.
  • Enzo Biochem, Inc. made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2366 holding.
  • BlackRock Institutional Trust first reported a position in Enzo Biochem, Inc. in Q2 2013 and has held it in 15 quarters since.
  • 109 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.